Iron chelation with deferasirox in a patient with de-novo ferroportin mutation

Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
Sule UnalFatma Gumruk

Abstract

Ferroportin disease is a rare type of autosomal dominantly inherited hemochromatosis caused with mutations in the ferroportin gene (SLC40A1). The patients characteristically have hyperferritinemia but normal transferin saturations. Herein, we present a 15-year-old female whose chief complaint was persistent nausea for the last one year. Extensive work-up including brain imaging revealed nothing to explain the etiology of nausea. The serum ferritin level of 1474ng/mL was suggestive for hemochromatosis syndromes and the molecular testing revealed de-novo c.485_487delTTG (P.Val162del) ferroportin gene mutation. Mild hepatic iron loading, in addition to the cumbersome nausea were accepted as indications for chelation treatment in this particular patient and deferasirox was initiated (10mg/kg/day) since family did not consent for phlebotomy. Deferasirox was stopped by the 9th month of initiation, since nausea subsided and hepatic iron content was normalized, in order to prevent over chelation. There are no well-established guidelines for the chelation of patients with hereditary hemochromatosis syndromes. However, lifelong monitorization for iron loading and re-initiation of chelation when necessary was planned in our patient.

References

Jul 19, 2002·Blood·Antonella RoettoClara Camaschella
Feb 6, 2004·Blood Cells, Molecules & Diseases·Antonello Pietrangelo
Mar 2, 2005·Best Practice & Research. Clinical Haematology·Antonella Roetto, Clara Camaschella
Jun 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ivana De DomenicoJerry Kaplan
Dec 15, 2005·British Journal of Haematology·L CremonesiMario Cazzola
Sep 9, 2011·Seminars in Liver Disease·Jodie L Babitt, Herbert Y Lin
Jul 6, 2014·Clinical Pharmacokinetics·Chiaki Tanaka
Jul 30, 2014·Hematology/oncology Clinics of North America·Maria Marsella, Caterina Borgna-Pignatti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.